Michael Fons
First SEC filing: Aug. 23, 2007 · Latest: Aug. 23, 2007
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 30, 2009 | INO | A | 40,000 | $1.57 | $62,800 | 40,000 Direct | · | Acquired | -98.5% (price as of 2026-10-05) |
| Dec. 9, 2008 | INO | A | 20,000 | $0.50 | $10,000 | 20,000 Direct | · | Acquired | -95.2% (price as of 2026-10-05) |
| July 9, 2008 | INO | A | 60,000 | $1.06 | $63,600 | 60,000 Direct | · | Acquired | -97.7% (price as of 2026-10-05) |
| Feb. 1, 2008 | INO | A | 20,000 | $0.88 | $17,600 | 30,000 Direct | +200.00% | Acquired | -97.3% (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Sept. 30, 2009 | INO | Common Stock Option | Common Stock | $1.57 | Sept. 30, 2019 | 40,000 | Acquired |
| Dec. 9, 2008 | INO | Common Stock Option | Common Stock | $0.50 | Dec. 9, 2018 | 20,000 | Acquired |
| July 9, 2008 | INO | Common Stock Option | Common Stock | $1.06 | July 9, 2018 | 60,000 | Acquired |
| Feb. 1, 2008 | INO | Common Stock Option | Common Stock | $0.88 | Feb. 1, 2018 | 20,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 5 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Aug. 23, 2007 | INO | Inovio Biomedical Corporation Common Stock | 25 | Direct |
| Aug. 23, 2007 | INO | Inovio Biomedical Corporation Common Stock Option | 37,500 | Direct |
| Aug. 23, 2007 | INO | Inovio Biomedical Corporation Common Stock Option | 20,000 | Direct |
| Aug. 23, 2007 | INO | Inovio Biomedical Corporation Common Stock Option | 20,000 | Direct |
| Aug. 23, 2007 | INO | Inovio Biomedical Corporation Common Stock Option | 25,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2008 | $197,061 | · | · | $59,833 | · | · | $3,220 | $260,114 |
| 2007 | $188,180 | $16,625 | · | $81,877 | · | · | $3,324 | $290,006 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.